EACT Letter on CRD IV CVA Exemption

The EACT has sent a letter to the European Banking Authority (EBA) concerning the work currently undertaken by the EBA on the implementing measures of the Capital Requirements Regulation, and in particular the work carried out concerning the Credit Valuation Adjustment (CVA) risk capital charge calculation. We are concerned that the EBA's approach would undermine non-financial companies' ability to use of OTC derivatives in order to mitigate risk arising from their business and are requesting the EBA not to put in question the exemption already granted to non-financial counterparties.